Stocks and Investing Stocks and Investing
Mon, October 9, 2023

Joseph Stringer Maintained (ALNY) at Strong Buy with Decreased Target to $200 on, Oct 9th, 2023


Published on 2024-10-28 06:46:40 - WOPRAI, Joseph Stringer
  Print publication without navigation


Joseph Stringer of Needham, Maintained "Alnylam Pharmaceuticals, Inc." (ALNY) at Strong Buy with Decreased Target from $240 to $200 on, Oct 9th, 2023.

Joseph has made no other calls on ALNY in the last 4 months.



There are 8 other peers that have a rating on ALNY. Out of the 8 peers that are also analyzing ALNY, 2 agree with Joseph's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Olivia Brayer of "Cantor Fitzgerald" Reiterated at Hold and Held Target at $190 on, Thursday, September 14th, 2023
  • Michael Ulz of "Morgan Stanley" Reiterated at Hold and Held Target at $210 on, Friday, August 4th, 2023


These are the ratings of the 6 analyists that currently disagree with Joseph


  • Luca Issi of "RBC Capital" Reiterated at Buy and Held Target at $270 on, Friday, October 6th, 2023
  • Gary Nachman of "Raymond James" Initiated at Buy and Held Target at $208 on, Friday, September 29th, 2023
  • Patrick Trucchio of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $405 on, Monday, September 18th, 2023
  • Paul Matteis of "Stifel" Reiterated at Strong Buy and Held Target at $240 on, Thursday, September 14th, 2023
  • Keay Nakae of "Chardan Capital" Reiterated at Strong Buy and Held Target at $250 on, Tuesday, August 8th, 2023
  • David Lebovitz of "Citigroup" Maintained at Strong Buy with Increased Target to $266 on, Friday, August 4th, 2023

Contributing Sources